Tim was responsible for building the commercial team at GelTex and launching Renagel, a novel treatment for patients with kidney failure that grew to a $1B franchise . Lucas Guevara is a Compliance Associate at RA Capital Management. owned by. Candice previously worked as the Director of Executive Office and Administration at Flywire. TJ is a Fund Accountant at RA Capital Management. Most recently Risa created and led the GE Ventures New Business Creation team which founded seven new businesses across multiple industries including healthcare, aviation, and energy. Sarah earned her BA from Harvard College in East Asian Studies and her JD from Harvard Law School. Parker works on both public and private investments, with a focus on diagnostics. Prior to RA, Christy was a Senior Scientist in Oncology Target Discovery at Pfizer. Sarah is the only lawyer to have received the NVCA’s Outstanding Service Award, for her leadership role in conceiving of and spearheading the NVCA Model Legal Documents. 1: names of reporting persons. She works with RA’s newcos to develop optimal pitch decks and public messaging, develops educational materials for the firm’s internal and external business courses, authors articles, and presents at conferences on concepts such as the biotechnology social contract that she and colleagues have written on. Previously, Jake covered solid tumor oncology landscapes. Sam’s primary responsibility is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. As Head of Engagement, Jessica Sagers directs a concerted effort at RA Capital Management to analyze, design, and shape internal and external narratives. Natalie is a Senior Program Manager at RA Capital working closely with the firm’s Managing Partner, Peter Kolchinsky, on a wide array of internal and external initiatives. Chris has a BS in Neurobiology and Behavior from Cornell University and a MA in Journalism from New York University. i.r.s. This helps us to provide you with a good experience when you browse our website, and also allows us to improve our site. Kaleen’s primary responsibility is to oversee the initiation, planning, and execution of various projects within the TechAtlas Division. Adam Rosenberg is a Venture Partner at RA Capital Management. She has a BA in Liberal Studies from Endicott College and a Certificate in Interior Design from Parsons School of Design. Item 4. She holds a BS in Business Administration from Wayne State University. Citizenship or Place of Organization Delaware : Number of Shares Beneficially Owned by Each Reporting Person With: 5. Her primarily responsibilities are to assist with all finance operations related to the Firm. Prior to GE Ventures Risa was a partner at Kleiner Perkins Caufield & Byers where she founded and developed therapeutics, tools, and molecular diagnostics companies. from Harvard College and an M.B.A. from Harvard Business School. Alyssa previously worked as a Senior Scientist at Eagle Pharmaceuticals. Bethany is a Finance Associate at RA Capital Management. After the acquisition, Tim was named President of Genzyme’s Renal Division and GelTex Pharmaceuticals. Intelligent Assistance and Bots Ecosystem. Prior to this role, Ryan was an Associate on the Cardio-Renal Team within the TechAtlas division of RA Capital, where he mapped competitive landscapes of drugs and medical devices for disease indications and capabilities, with a focus on coronary artery disease, stroke, and dyslipidemia. RA Capital Management, LLC (the "Adviser") is the general partner of the Fund and the investment adviser of the Account. Jacqueline a Research Assistant at RA Capital Management. Currently, their heaviest sector is Health Care — making up 82.7% of the total portfolio value. Rajeev Shah is a Managing Partner at RA Capital Management. Citizenship or Place of Organization Delaware : Number of Shares Beneficially Owned by Each Reporting Person With: 5. Chris’ primary responsibility at RA Capital is to oversee the firm’s information technology program, including operations, development, and security. Rajeev Shah has served as a member of our board of directors since March 2017. Fabio previously worked as an MBA Associate at F-prime Capital in the UK and Versant Ventures in Canada. Cristina Montero is an Associate Director within the TechAtlas division of RA Capital Management. Rebecca Silberman is an Associate with the TechAtlas division of RA Capital Management. Rajeev Shah. Alex has a BS in Chemistry and a Minor in Religious Studies from Davidson College. Prior to joining RA, Jim was the President and CEO of the Biotechnology Innovation Organization (BIO), the world’s largest biotechnology trade association, where he worked on international, federal, and state policies aimed at helping innovative biotech companies succeed. Her primary responsibilities are to support our Venture Team by coordinating management agendas, calendars, and external events. Tim was hired as the fourth employee at Proteon and built a team that brought an innovative biologic for blood vessel remodeling from pre-clinical through two Phase 3 clinical trials. identification nos. Prior to this role, Cristina mapped a number of competitive landscapes, including respiratory, allergic, and infectious disease conditions. Adam has led and advised companies in diverse areas such as digital health, materials and diagnostics, and has served as Director on the board of multiple venture-backed companies. Kaleen Sullivan is a Project Coordinator at RA Capital Management. Andrew Senesi is an Associate in Global Innovation within the TechAtlas division of RA Capital Management. He worked previously as a freelance graphic designer. Rebecca’s primary responsibility is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Mr. Rajeev Shah is a Partner and Portfolio Manager at RA Capital Management, LLC and is a part of the research and portfolio management team at the firm. Monica holds a BSc in Neuroscience and Pharmacology from the University of Toronto and a PhD in Cancer Biology from MIT. Ra Capital Management Llc is a hedge fund that manages 1.8 BN dollars in regulatory AUM and has 34 employees, of which 26 perform investment advisory functions. Matthew’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. James was most recently the founder, Chief Executive Officer, and served as a Board Director for Imara, a public company developing therapies for sickle cell disease and β-thallasemia. He was a faculty member at the University of Rochester School of Medicine prior to joining Merck Research Laboratories in 2004. His doctoral research focused on cellular mechanisms of adipogenesis. Erich’s primary responsibilities are to drive internal and external strategic and diligence initiatives and oversee the workflow and professional development of TechAtlas Associates. Klio’s primary responsibilities at RA Capital are to oversee talent development, recruiting, people operations, and culture. Benjamin’s primary responsibilities at RA Capital are to coordinate various projects across the Venture Team and oversee their initiation, planning, and execution. Identification Nos. 1: names of reporting persons. Max’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Ryan Berry is an Analyst on the Investment Team at RA Capital Management. Rajeev Shah investment strategy. delaware . He holds a BA in History from University of Massachusetts, Amherst and a Master's of Urban Affairs from Boston University. Matt comes to RA from Localytics where he served as a Senior Software Engineer for the past two years. Rajeev M. Shah is Class B Member, Portfolio Manager at Ra Capital Management Llc and has been affiliated with Ra Capital Management Llc since January-2012. Cristina holds a BA in Molecular Biology with a minor in Business from Washington University in St. Louis, and a PhD in Microbiology and Molecular Genetics from Harvard University. Brittany’s primary responsibilities at RA Capital are to coordinate calendars, events, and company meetings for the Operations division as well as assist in all of the firm’s recruiting efforts. Nicole previously worked as a Business Systems Technician at Jacobs Engineering Group. Alex’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Milind attended the residential Executive Program at The Wharton School of Management. Ramin is an experienced clinical trialist and previously led global clinical development programs at Akebia Therapeutics and Gilead Sciences. RA Capital makes no guarantees as to their accuracy or completeness. with: 0. Chris’s primary responsibility at RA Capital is to cover the biotech and pharma industry. Christina’s primary responsibility is to edit and guide development of competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Jesse Chen is an EIR at RA Capital. He previously worked as a Help Desk Manager at Toast. Sarah Reed is the General Counsel at RA Capital Management. The fund focuses on investments in the United States as 82.1% of the portfolio companies are based in the United States. 0. beneficially. Mr. Shah is a Managing Director and Portfolio Manager at RA Capital Management, LLC, or RA Capital, an investment management company. Brett holds a BS from Washington University, St. Louis and a JD from Duquesne University School of Law and is admitted to practice law in PA. Brett previously served as a Clerk for the Washington County Court of Common Pleas in PA. Emilie Schleer is the Senior Investor Relations Manager with the Operations Team at RA Capital Management. David holds a PhD from Harvard University in Biophysics and a BS in Molecular Biology from Texas A&M University. 0 . She has a BA in Communication Studies from University of Minnesota, Twin Cities. Raj previously worked as a Senior Project Leader at Altus Pharmaceuticals, a spin-off company of Vertex Pharmaceuticals, where he assessed business processes and implemented system solutions across all areas of science. Stefanie Feldmann is the Senior Executive Assistant to the Co-founders and Senior Operations Manager. David is an Associate within the TechAtlas division of RA Capital Management. ABOUT RA CAPITAL . Prior to RA, TJ was at KPMG where he was a Senior Audit Associate. His doctoral research focused on the regulation of the ERK/MAPK pathway by adenylyl cyclases during long-term memory formation and sensitization to drugs of abuse. She has a PhD in Neuroscience from MIT and prior to her time at Athenen, she worked as an Associate on the Tech Atlas team at RA Capital, covering Neuro, GI, and Orphan indications. Currently, their heaviest sector is Health Care — making up 82.7% of the total portfolio value. Emilie has previously held similar roles at FLAG Capital Management and Bain Capital. number of. We look forward to providing you with even more cutting-edge market research, as Topio Networks. Katie’s primary responsibilities are to advise on regulatory matters and assist in the development, implementation, and testing of the compliance program. 0. Nothing contained on the website constitutes investment advice, and the views expressed should not be taken as advice to buy, sell, or hold any security or as an endorsement of any security or company. Her doctoral research focused on bacteriophage-mediated regulation of bacterial transcription. Laura’s primary responsibility at RA Capital is to identify compelling assets to help facilitate new company creation or investments in emerging seed-stage companies. Andrew’s primary responsibility is to help guide internal software development to support competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. He holds a Bachelor’s degree in Electronics and Communications from Anna University, and a Master’s degree in Computer Science from Northeastern University. of above persons (entities only) ra capital management, l.p. 2: check the appropriate box if a member of a group (see instructions) He holds a BA from Cornell University and a PhD in Virology from Harvard University. Lucas holds a BA in Criminal Justice and Philosophy from John Jay College of Criminal Justice in NY, a JD, Privacy Concentration, from Northeastern University School of Law, and is admitted to practice law in MA. SECURITIES AND EXCHANGE COMMISSION. 0. Peter is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools and serves on the boards of publicly- and privately-held life science companies. Ana holds an MPH in Epidemiology and Biostatistics from Boston University School of Public Health and a BA in Neuroscience from Boston University. Jim Greenwood is an Advisor at RA Capital. As the first and founding member of Kymera’s scientific team, Jesse was responsible for building the company’s industry-leading targeted protein degradation platform and pipeline, and he helped secure the company’s Series A and B financings as well as a partnership with Vertex. Nadim has 11+ years’ experience in commercializingdrug discovery across diverse indications and modalities. Why work with RA Capital? Raj Shah is Mng Dir/Portfolio Mgr at RA Capital Management LLC. RA Capital Management, L.P. 2. Jake Simson is a Partner at RA Capital Management. Prior to joining Aberdeen, Eric worked as a Compliance Examiner at the US Securities and Exchange Commission. Astha holds a BA in Biochemistry and Molecular Biology (with a minor in Physics) from Clark University. Gerald’s primary responsibility is to leverage RA Capital’s TechAtlas platform to identify differentiated opportunities for new venture formation. Prior to Not Your Average Joe's, Ebony held roles in payroll and human capital management, as well as banking at Solex HCM and Rockland Trust Bank. She previously held Executive Assistant and Senior Executive Assistant roles at Genuity Science, Charles River Laboratories, and Gloucester Graphics, Inc. Amber has a dual BA concentration in International Business & Modern Languages from Northeastern University and studied abroad at American University of Paris. Prior to MPM, Sarah was the General Counsel for Charles River Ventures and before that, at Palomar Medical Technologies. www.vbprofiles.com is now www.topionetworks.com. Identification Nos. Sara previously worked as an Executive Assistant at Battery Ventures. Mariagrace previously worked as an Executive Assistant at MPM Capital. Laura’s primary responsibilities at RA Capital are to coordinate calendars, events, and company meetings for the TechAtlas division. Adison previously held posts as an Administrative Assistant and Office Manager at Dyer Brown Architects and as an Executive Assistant to the Principal and Office Manager at bKL Architecture. i.r.s. Jeff holds a BA in Economics and Psychology from Georgetown. Astha is a Research Assistant at RA Capital Management. The general partner of RA Capital is RA Capital Management GP, LLC, of which Dr. Kolchinsky and Mr. Shah are the controlling persons. John holds a BA in Sociology and Criminal Justice from the University of Massachusetts, Amherst. Statement of Acquisition of Beneficial Ownership by a Passive Investor - Seq. RA Capital Management is a Multi-Stage Investment Manager. Prior to Foghorn, Tess held finance leadership roles at Wave Life Sciences, where she was responsible for FP&A and corporate finance, and Biogen, where she was the finance lead for the CMO and the neurodegeneration portfolio. Meredith’s previous experience includes Medical Education Researcher and Medical Scribe positions at BMC Global Inc. and Longwood Pediatrics, respectively. As Engagement Associate at RA Capital Management, Thomas Culman leverages qualitative and quantitative skills to manage a variety of educational, outreach, and advocacy-oriented projects. identification nos. He previously worked as a corporate attorney at Foley Hoag LLP and Cooley LLP. Michael is a CPA. She is involved with the firm’s back office and trade operations. Executive Assistant and Recruiting Coordinator. Prior to that, David worked as Director of Operations for Wingspan Investment Management, LP and held operations positions at Brencourt Advisors and Silver Point Capital, LP. Her graduate research investigated novel epigenetic regulators in glioblastoma. Mr. Shah worked as a Senior Project Leader and managed technical operations at Altus Pharmaceuticals. Raj is active in both public and private investments in companies developing drugs, medical devices, diagnostics, and research tools. in Linguistics and Musicology from Freie Universitat Berlin, Germany. SEC Use Only : 4. Briana’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Gerald is the Director of Scientific Operations at RA Capital Management. Lorena has dual degrees from Beijing Foreign Studies University: a Bachelor of Business Administration in Accounting and a Bachelor of Arts in English Literature. 0 shares: 6. Jacqueline’s primary responsibility is to conduct research and analysis for competitive landscapes of drugs and medical devices across a range of disease indications and capabilities. Brittany previously worked as a Delivery Specialist at Randstad Technologies. Josh’s primary responsibility at RA Capital is to lead early-stage private investments in and oversee the creation of new companies developing drugs, medical devices, diagnostics, and research tools. Christina is a Senior Science Writer at RA Capital Management. of above persons (entities only). He holds a BSE in Mechanical Engineering from Princeton University, a PhD in Biomedical Engineering from the Massachusetts Institute of Technology, and an MD from Harvard Medical School. Alonso Ricardo is an Entrepreneur in Residence at RA Capital, where he works closely with RA’s Venture Team to evaluate drug discovery platforms and initiate novel therapeutics programs. Brett Scheller is a Compliance Associate at RA Capital Management. Sarah joined our team from MPM Capital where she served as the COO & General Counsel. This transaction was executed in multiple trades at prices ranging from $2.15 to $3.31; the price reported above reflects the weighted average sale price. Shah has been a managing partner at RA Capital Management, L.P., a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics, since 2004. Her primary responsibilities are to support our Venture Team by coordinating management agendas, calendars, and external events. This Joint Filing Agreement, dated as of January 29, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P. (the foregoing are collectively referred to herein as the “Filers”). This Joint Filing Agreement, dated as of February 19, 2021, is by and among RA Capital Management, L.P., Peter Kolchinsky, Rajeev Shah, and RA Capital … Nathaniel is a Principal on the Venture Team at RA Capital Management. of above persons (entities only) ra capital management, l.p. 2: check the appropriate box if a member of a group (see instructions) RA CAPITAL MANAGEMENT, L.P. Total Shares: 0 Subject Company: Iterum Therapeutics Plc - View Complete Ownership History Backtest Filed as of Date: 02/11/2021: Event Date: 02/09/2021: Overall % Ownership: 0.0% Under his leadership, Therapeutics Alliances advanced 40+ projects, including 11 projects partnered with biopharma or new startups such as Repare Therapeutics and GliXogen Therapeutics. Her primary responsibilities are to manage payroll and benefit programs for the company. Christy’s primary responsibility at RA Capital is to create competitive landscapes of drugs and medical devices for disease indications and capabilities. Our website uses cookies to distinguish you from other users of our website. He worked previously as the Director of Business Systems at Bain Capital Credit, and as a Senior Systems Analyst at eSecLending, LLC. Rajeev Shah Citizenship or Place of Organization United States Check if the Aggregate Amount in Row (9) Excludes ¨ Certain Shares (See Instructions) Names of Reporting Persons. Prior to joining biotech/pharma, she was a specialist in the corporate finance team at McKinsey &Co, focused on corporate transactions. Tim began his career at Merck & Co., serving in multiple commercial roles in its cardiovascular, gastrointestinal, and managed care divisions. John DiNapoli is the Systems Administrator at RA Capital Management. Ana is a Research Assistant at RA Capital Management. Prior to joining RA Capital and Arcuate Therapeutics, Tim was President and CEO of Proteon Therapeutics, a company focused on developing novel therapeutics to improve the lives of patients with kidney and vascular diseases. See Raj Shah's compensation, career history, education, & memberships. Prior to co-founding Therapeutics Alliances, Nadim worked in NYU’s Industrial Liaison technology transfer group, and was a Research Analyst at the International AIDS Vaccine Initiative. Benjamin previously worked in clinical research as a Site Operations Associate for a contracted research organization specializing in Ophthalmology. Alonso was also a chemistry professor at the Universidad de los Andes in Colombia. Partner at RA Capital Management and President of the Rockerfeller Foundation owns 10 Million shares, representing 18.9% ownership in the company. Michael Ryan is an EIR at RA Capital. Erin holds a Bachelor of Fine Arts degree from the Massachusetts College of Art & Design. Jeff Breay is a Head Trader at RA Capital Management. He was Chief Medical Officer of Ra Pharmaceuticals from 2016 until it was acquired by UCB in 2020. TJ has a BS in Business Administration with a concentration in Accounting from Northeastern University. Mr. Shah has has served as a member of our board of directors since July 2015. Sole Voting Power . Shan Shan holds a PhD in Neuroscience from Harvard University and a BS in Brain and Cognitive Sciences from MIT. Michael Gillespie is an Associate within the TechAtlas division of RA Capital Management. Sarah teaches a course at Harvard Law School on venture capital fund formation. Klio also partners with portfolio companies to provide guidance and thought leadership and to support the creation of HR procedures and programs. with: 5: sole voting power . Alex is a Junior Associate with the TechAtlas division of RA Capital Management. Max has a BS in Biology from the State University of New York at Fredonia and a PhD in Cellular and Molecular Biology from the University of Michigan. We are dedicated to evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, and diagnostics. Candice Galvez is an Executive Assistant at RA Capital Management. His research investigated chromatin structure and transcription factor binding. each. Nate has a BS in Biological Sciences from University of Vermont. Derek DiRocco is a Partner at RA Capital Management. Fabio holds a BSc in Biotechnology from the Universita Federico II, a PhD in Cell and Molecular Biology from the University of Edinburgh, and an MBA from the London Business School. Jon has a PhD in Biomedical Engineering from the University of Michigan, an MS in Mechanical Engineering from Boston University, and a BS in Physics from the University of Washington. Mr. Shah has been a managing partner at RA Capital Management, L.P., a multi-stage investment manager dedicated to evidence-based investing in public and private healthcare and life science companies that are developing drugs, medical devices, and diagnostics, since 2004. Katie Maher is a Senior Compliance Officer at RA Capital Management. Senior Executive Assistant and Senior Operations Manager. Astha’s previous experience includes Research Assistant roles at Clark University and Corbus Pharma. 7: sole dispositive power . Laura has a BS in Human Services; Clinical Concentration and a Minor in Disabilities Studies from the University of Delaware. Laura holds a BA in Biology and Psychology from Harvard University, and a PhD in Neuroscience from MIT. Partner at RA Capital Management and President of the Rockerfeller Foundation owns 10 Million shares, representing 18.9% ownership in the company. Michael Calore is the Director of Investor Relations at RA Capital Management. Lucas previously held Law Clerk positions at The Community Builders, Inc. and at Nixon Peabody LLP. Finally, RA Capital Healthcare Fund owns 8,486,000 shares, representing 16.5% ownership in the company. Rajeev Shah Board Member Managing Director & Portfolio Manager, RA Capital. Her primary responsibilities are to coordinate calendars, events, and company meetings. Pieter’s primary responsibility at RA Capital is to lead major strategic initiatives and drive operational excellence across the firm. At Altus, he assessed business processes and implemented system solutions for all science areas. Andrew Levin joined RA Capital Management in 2015 and is a Managing Director on the Investment Team and spearheads a drug discovery effort that has led to the formation of several new companies. From time to time we may post specific open positions, but more often we will create positions for the right people. Prior to Citigroup, Michael held various accountant and analyst roles at EY, Morgan Stanley, BBH, and Deloitte. David holds a BS in Economics with a minor in Business Administration from University of Colorado Boulder. James was an entrepreneur in residence at HealthCare Ventures, an advisor to Kurma Ventures, and is on the Scientific Advisory Board and Board of Directors of the Friedreich’s Ataxia Research Alliance (FARA), a patient advocacy group. In preparing the information contained in this website, RA Capital has not taken into account the investment needs, objectives, and financial circumstances of any particular investor, and investments and companies referenced may not be suitable for all investors. His responsibilities include managing the portfolio’s public equity positions, monitoring market, sector, and individual equity dynamics, and maintaining relationships with broker/dealer counterparties. Address of Principal Business Office or, if None, Residence: The address of the principal business office of each of the Reporting Persons is: c/o RA Capital Management, L.P., 200 Berkeley Street, 18 th Floor, Boston MA 02116 . Derek works on both public and private investments and serves as a Board Director for 89Bio, Achilles Therapeutics, iTeos Therapeutics, Connect Bio, CANbridge, and Werewolf Therapeutics.

Superfast Hurricane Laminate Flooring Sage, Dahli Dragula Instagram, Black Friday Pocket Knife Deals 2020, Famicom Castlevania 3 Rom, Ct Tax Look Up, 2011 Chevy Cruze Valve Cover Gasket, Carter Family Crest Meaning, Tackle Warehouse Buzzbaits,